A new trial suggests GLP-1 weight-loss drugs such as semaglutide could also curb heavy alcohol use. Researchers report weekly injections halved heavy drinking days among adults with alcohol use disorder. Because the same medicine is already used for obesity, the findings could translate into a new treatment pathway for millions, pending further research.
A new trial explored whether type 2 diabetes patients could get both improved blood sugar control and weight benefits from a single endoscopic procedure called duodenal mucosal resurfacing. Participants either received the procedure or underwent a sham version, letting researchers compare outcomes while minimizing bias. Results could reshape how doctors approach metabolic control in the future.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
